Aging and vascular dysfunction: beneficial melatonin effects by Favero, Gaia et al.
IJAE 
Vo l .  116 ,  n .  1  (Supp lem ent) :  72 ,  2011
© 2011 Firenze University Press 
ht tp://www.fupress .com/ijae
ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY
aging and vascular dysfunction: benefi cial melatonin 
eﬀ ects
Gaia  Favero1, Claudia  Rossini1, Eleonora  Foglio1, Francesca  Bonomini1, Russel J.  Reiter2 , Rita 
 Rezzani1
1 Sezione di Anatomia Umana, Dipartimento di Scienze Biomediche e Biotecnologie, Università degli Studi di 
Brescia, Italia
2 Department of Cellular and Structural Biology, University of Texas Health Science Center, San Antonio, Texas, 
USA
The study of biological aging has seen spectacular progress in the last decade. 
Aging is characterized by a progressive deterioration of physiological functions and 
metabolic processes. Moreover, aging is accompanied with the development of age-
related diseases, such as cardiovascular diseases, which are the major causes of mor-
bidity and mortality in the developed nations.
Sirtuin1 (SIRT1) is a well investigated member of the sirtuin family of protein dea-
cetylases which has attracted attention as a potent mediator of life span extension.
Recently, melatonin, a pleiotropic molecule which functions as a highly eff ective 
antioxidant and free radical scavenger, was shown to activate SIRT1 in primary neu-
rons of young animals, as well as in aged neurons of a murine model of senescence. 
Melatonin is known to modulate oxidative stress-induced senescence and pro-surviv-
al pathways.
We treated ApoE-defi cient mice with two melatonin formulations (kindly provid-
ed by Nathura s.r.l, Reggio Emilia, Italy), showing diff erent pharmacokinetic: mela-
tonin Fast, rapid-release formulation, and Retard, extended-release formulation.
Morphological changes in vessels were evaluated using histological procedures 
and immunohistochemical analyses of SIRT1, p53, eNOS and ET-1 markers. We 
demonstrate that SIRT1 and eNOS dropped dramatically in ApoE mice and that 
atherogenesis induced an elevated expression of p53 and ET-1. Melatonin not only 
improved the impairment of endothelial damage, but also reduced the loss of SIRT1 
and eNOS decreasing p53 and ET-1 expression. Also, the extended-release melatonin 
preparation (Retard) caused a greater improvement of aorta cytoarchitecture.
In summary, our fi ndings implicated the SIRT1-p53-eNOS axis as one of the 
important process involved in endothelial senescence. Moreover, the role of SIRT1 
as a driver of cellular stress resistance and longevity is noteworthy in the context of 
its expression profi le. Finally, we suggest that extended-release melatonin provides 
a more appropriate option for cellular longevity compared with rapid-release mela-
tonin administration.
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